Theophylline therapeutics drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administrationSTEINIJANS, V. W; TRAUTMANN, H; SAUTER, R et al.Annual review of chronopharmacology. 1990, Vol 7, pp 323-326, issn 0743-9539, 4 p.Conference Paper

Clonidine reverses methylxanthine-induced potentiation of baclofen antinociceptionSTEARDO, L; SAWYNOK, J.Pharmacology, biochemistry and behavior. 1985, Vol 22, Num 5, pp 905-907, issn 0091-3057Article

Thermochemical study of theophylline and its hydrateSUZUKI, E; SHIMOMURA, K; SEKIGUCHI, K et al.Chemical and pharmaceutical bulletin. 1989, Vol 37, Num 2, pp 493-497, issn 0009-2363, 5 p.Article

Antineoplastic effect of the xanthine derivative trentalBIDDLE, W; AMBRUS, C. M; GASTPAR, H et al.Journal of medicine (Westbury). 1984, Vol 15, Num 5-6, pp 355-366, issn 0025-7850Article

Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivativesJOHNSON, H. G; MCNEE, M. L.British journal of pharmacology. 1985, Vol 86, Num 1, pp 63-67, issn 0007-1188Article

Effect of environmental temperature on the elimination of theophyllineMATSUYAMA, K; SAWAHARA, H; NODA, A et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 5, pp 2026-2029, issn 0009-2363Article

Efficacy of enprofylline, a new bronchodilating xanthine, in acute asthmaBOE, J; ERIKSSON, G; LJUNGHOLM, K et al.Annals of allergy. 1987, Vol 59, Num 2, pp 155-158, issn 0003-4738Article

Proceedings/Update on theophylline, symposium, September 4-6, 1985, Bethesda, MDGRANT, J. A; ELLIS, E. F.Journal of allergy and clinical immunology. 1986, Vol 78, Num 4, pp 669-824, issn 0091-6749, 2Conference Proceedings

Limitation of theophylline elimination by reduced oxygen availability in mouse hepatocytes and rat isolated liversNAKATSU, K.Canadian journal of physiology and pharmacology. 1985, Vol 63, Num 8, pp 903-907, issn 0008-4212Article

Presence of theophylline in seminal fluid and impairment of spermatogenesis associated with repeated theophylline administration in dogsPULL, L; MICHEL, A; CROS, G et al.Journal de pharmacie clinique (Paris). 1985, Vol 4, pp 303-310, issn 0291-1981, h. sér. 1Article

Theophylline: primary or tertiary drug? a brief reviewMARKS, M. B.Annals of allergy. 1987, Vol 59, Num 2, pp 85-87, issn 0003-4738Article

PACPX: a substituted xanthine-antagonizes both the A₁ and A₂ subclasses of the P₁-purinoceptor ― Antagonism of the A₂ subclass is competitive but antagonism of the A₁ subclass is notBURNSTOCK, G; HOYLE, C. H. V.British journal of pharmacology. 1985, Vol 85, Num 1, pp 291-296, issn 0007-1188Article

Adenosine analogs: potentiation of bradykinin-induced plasma exudation in rat skin and prevention by caffeine and theophyllineSUGIO, K; DALY, J. W.Life sciences (1973). 1984, Vol 35, Num 15, pp 1575-1583, issn 0024-3205Article

Methylxanthines: toxicity to humans. I: TheophyllineSTAVRIC, B.Food and chemical toxicology. 1988, Vol 26, Num 6, pp 541-565, issn 0278-6915Article

Determination of theophylline binding to human serum proteins by isotachophoresisREIJENGA, J. C; GAYKEMA, A; MIKKERS, F. E. P et al.Journal of chromatography. 1984, Vol 287, Num 2, pp 365-370, issn 0021-9673Article

Theophylline reassassedBUKOWSKYJ, M; NAKATSU, K; MUNT, P. W et al.Annals of internal medicine. 1984, Vol 101, Num 1, pp 63-73, issn 0003-4819Article

Substrate specificity on enhancement of aminophylline-stimulated thermogenesisLEE, T. F; WANG, L. C. H.Journal of thermal biology. 1987, Vol 12, Num 2, pp 73-76, issn 0306-4565Article

Adenosine-induced bronchoconstriction in asthma: antagonism by inhaled theophyllineCUSHLEY, M. J; TATTERSFIELD, A. E; HOLGATE, S. T et al.The American review of respiratory disease. 1984, Vol 129, Num 3, pp 380-384, issn 0003-0805Article

CLINICAL EFFICACYTRIAL: THEOPHYLLINE VS (DL)3,7-DIHYDRO-1,8-DIMETHYL-3-(2-METHYLBUTY)-1H-PURINE-2,6-DIONEGRASSI C; CASALI L; RAMPULLA C et al.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 12; PP. 518-522; BIBL. 5 REF.Article

Effets antioxydants potentiels de la pentoxifylline = Potential antioxidative effects of pentoxifyllineFREITAS, J. P; FILIPE, P; GUERRA RODRIGO, F et al.Comptes rendus des séances de la Société de biologie et de ses filiales. 1995, Vol 189, Num 3, pp 401-405, issn 0037-9026Article

Doxofylline differs from methylxanthines in its movement of cytosolic calciumFRANZONE, J. S; CIRILLO, R; REBOANI, M. C et al.International journal of tissue reactions. 1991, Vol 13, Num 3, pp 131-138, issn 0250-0868Article

Pharmacokinetics of theophylline in preterm neonates during the first month of lifeISLAM, Samira I; ALI, Ahmed S; SHEIKH, Amal A et al.Saudi medical journal. 2004, Vol 25, Num 4, pp 459-465, issn 0379-5284, 7 p.Article

Evaluation of theophylline population pharmacokinetics in adult hospitalized patients using NONMEM analysisLI ZHEN; CHEN GANG.Zhōngguó yàoli xuébào. 1994, Vol 15, Num 3, pp 267-270, issn 0253-9756Article

Potentiation of thrombolytic therapy by enzyme combinations and with aspirin or pentoxifyllineAMBRUS, J. L; AMBRUS, C. M; STADLER, S et al.Journal of medicine (Westbury). 1994, Vol 25, Num 3-4, pp 145-161, issn 0025-7850Conference Paper

Abus des xanthines dans le sport: dyphyllineVALERO, F; DE LA TORRE, R; SEGURA, J et al.Science & sports. 1992, Vol 7, Num 2, pp 121-122, issn 0765-1597Article